Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer

Concurrent chemoradiotherapy (CRT) has been recommended and applied widely as the standard treatment for limited‐stage small cell lung cancer (LS‐SCLC). However, controversies remain regarding the optimal timing and treatment duration of thoracic radiotherapy (TRT), and their effects on patient surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shen, Zhou, Ting, Ma, Shuxiang, Zhao, Yuanyuan, Zhan, Jianhua, Fang, Wenfeng, Yang, Yunpeng, Hou, Xue, Zhang, Zhonghan, Chen, Gang, Zhang, Yaxiong, Huang, Yan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143999/
https://www.ncbi.nlm.nih.gov/pubmed/30019533
http://dx.doi.org/10.1002/cam4.1616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143999/
https://www.ncbi.nlm.nih.gov/pubmed/30019533
http://dx.doi.org/10.1002/cam4.1616

Ejemplares similares